Alambic Investment Management’s Rigel Pharmaceuticals RIGL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q3 | – | Sell |
-13,338
| Closed | -$364K | – | 573 |
|
|
2017
Q2 | $364K | Sell |
13,338
-450
| -3% | -$12.3K | 0.04% | 429 |
|
|
2017
Q1 | $456K | Sell |
13,788
-5,273
| -28% | -$174K | 0.06% | 426 |
|
|
2016
Q4 | $454K | Buy |
19,061
+2,310
| +14% | +$55K | 0.08% | 349 |
|
|
2016
Q3 | $615K | Sell |
16,751
-3,423
| -17% | -$126K | 0.14% | 245 |
|
|
2016
Q2 | $450K | Sell |
20,174
-7,116
| -26% | -$159K | 0.11% | 302 |
|
|
2016
Q1 | $568K | Buy |
27,290
+12,880
| +89% | +$268K | 0.18% | 199 |
|
|
2015
Q4 | $437K | Buy |
+14,410
| New | +$437K | 0.26% | 145 |
|